High-output testing iFyber recently launched high-throughput, surface-based assays for dental material biofilm testing, signaling a capability to handle scalable screening projects for dental devices and biomaterials.

Regulatory support The firm positions itself as a one-stop shop for custom pre-clinical studies, with experience supporting 510(k) submissions and responding to FDA reviewer requests, presenting a path to assist medical device companies navigating regulatory timelines.

Analytical expansion Expansion into advanced LC-MS services and new technical leadership indicates a strengthened analytical chemistry capability, offering deeper characterization services that could attract pharma, biotech, and device clients needing robust chemistries and metabolite analysis.

Award-backed credibility Recent collaboration with Merakris Therapeutics yielding Best Laboratory Research Award at SAWC reinforces credibility in wound care and regenerative medicine, presenting opportunities to engage stakeholders in those markets.

Growing diversification Diversified expertise across biocompatibility, antimicrobial, virology, coatings, and materials science, plus a multi-disciplinary PhD-driven team, suggests potential for cross-industry projects in medical devices, diagnostics, and consumer products seeking specialized testing and method onboarding.